In the current study, we analyzed the expression of Fas of relapse after BMT to a relative risk of 0.78 and 0.48, respectively. Furthermore T-cell depletion in allogeneic on AML cells from 64 cases in the context of CD34 and CD38 coexpression. In addition, we investigated clinical rel-BMT resulted in higher relapse rates. It has been well documented that in some cases recurrence of AML after BMT evance of Fas expression and the function of Fas. can be treated using donor lymphocyte infusions (DLI). T lymphocytes (CTLs) has been shown to be an important informed consent. The studies were performed on randomly selected mechanism of cell killing. 4 Fas is a cell surface molecule that directly mediates apoptosis. 
C
to undergo differentiation into nondividing cells. 10 Clonogenic capacity is generally considered to be associated with LINICAL EXPERIENCE FROM allogeneic bone marrow transplantation (BMT) for acute myeloid leukemia (AML) has suggested that immune mechanisms contriban immature phenotype. Lapidot et al reported that clonogenic potential of myeloid leukemia cells in vitro is restricted ute to the eradication of leukemia. 1 Occurrence of acute or chronic graft-versus-host disease (GVHD) reduced the risk to leukemia that had CD34 / CD38 0 phenotype. [11] [12] [13] [14] In the current study, we analyzed the expression of Fas of relapse after BMT to a relative risk of 0.78 and 0.48, respectively. Furthermore T-cell depletion in allogeneic on AML cells from 64 cases in the context of CD34 and CD38 coexpression. In addition, we investigated clinical rel-BMT resulted in higher relapse rates. It has been well documented that in some cases recurrence of AML after BMT evance of Fas expression and the function of Fas. can be treated using donor lymphocyte infusions (DLI). 2 In the autologous setting, in vivo and in vitro administration of
MATERIALS AND METHODS

interleukin (IL)-2 induces stimulation of cellular immunity
Clinical samples. Sixty-four newly diagnosed patients with to kill tumor cells by generating lymphokine-activated killer AML were included in this study. All patients received standard cells. 3 Various types of hematopoietic cells are involved in induction-therapy just after the diagnosis. The diagnosis of AML was the immunosurveillance against leukemia cells. T lymphocytes (CTLs) has been shown to be an important informed consent. The studies were performed on randomly selected mechanism of cell killing. 4 Fas is a cell surface molecule that directly mediates apoptosis. 5 Fas was first identified when a monoclonal antibody (MoAb) (anti-Fas) was developed that had cytolytic activity toward several Fas / cell lines. Molecu- sis of DNA fragmentation, 5 1 10 5 cells were mixed with 100 mL Cell preparations. MNCs were isolated using standard proceof 10 mmol/L Tris-HCl (pH7.4), 10 mmol/L EDTA and 0.5% Tritondures. Briefly heparinized cell samples were separated by Ficoll-X (Wako Pure Chemical Industries, Tokyo, Japan). The lysate was Hypaque density centrifugation at the time of collection to obtain incubated for 10 minutes at 4ЊC and then spun at 13,000g for 20 highly purified mononuclear cell fractions consisting mostly of leuminutes. The supernatant was incubated with ribonuclease A (RNase kemia blasts. The purified fractions were washed in phosphate-buf-A; Sigma Chemical Co, St Louis, MO) for 1 hour at 37ЊC and then fered saline (PBS). Nineteen samples were used immediately after Proteinase K was added to remove proteins. DNA was precipitated isolation and 45 samples were cryopreserved in RPMI 1640 in 1 vol isopropanol and 0.5 mol/L of NaCl, centrifuged, and sus-(GIBCO, Grand Island, NY) with 10% fetal calf serum (FCS) and pended in Tris-EDTA (TE) buffer. Extracted DNA solution was 10% dimethyl sulfoxide at 0196ЊC. On thawing, blasts were resusapplied to a 2% agarose gel, electrophoresed, and stained by ethidpended in culture medium and nonviable cells were removed by ium bromide. Ficoll centrifugation.
Apoptosis was measured by Colorimetric DNA-fragmentation Cell culture. All cell cultures were performed in RPMI 1640 assay to calculate the numbers of apoptotic DNA nuclei. The cultured with 10% FCS (culture medium) at 37ЊC in a humidified 5% CO 2 cells were pelleted, resuspended in 400 mL PBS (0.1% sodium ciatmosphere. Leukemia Chugai Pharmaceutical Co, Tokyo, Japan), granulocyte-macrophage Japan), which is known to induce apoptosis mimicking the FasL, colony stimulating factor (GM-CSF; 50 ng/mL; KIRIN Brewery Co, was used at the concentration of 1 or 0.2 mg/mL.
Flow cytometric analysis. To analyze for the expression of Fas and CD34 on AML cells, the following MoAbs were used: fluores- Tokyo, Japan), erythropoietin (Epo; 2 U/mL; KIRIN), and stem cell ied (Table 1) . Median percentages of Fas positivity in leukefactor (SCF; 50 ng/mL; KIRIN). After 7 days, colonies containing mia cells of each patient were 19.5% in M1 (n Å 9), 56.7% more than 20 cells were counted under an inverted microscope. In in M2 (n Å 26), 67.0% in M3 (n Å 6), 48.7% in M4 (n Å each experiment, five colonies were removed from the plate and 14), and 52.3% in M5 (n Å 6) (Fig 2) . RFI showed similar analyzed for their morphology. All cultures were performed in dupliresults ( of the induction of apoptosis by anti-Fas IgM in 24 cases is shown in . Similar with anti-Fas IgM at the concentration of 1 mg/mL, was data is shown in Table 3 . At any definition, there was no observed ( Table 4) . As shown in Fig 8 and Figure 4 shows representative results of flow cytometric (Fas õ20%) leukemias demonstrate induction of apoptosis, analysis of normal BM MNCs and leukemia cells. The rewhereas 13 of 19 Fas / leukemias showed borderline signifisults of two-color flow cytometric analysis was divided into cance (x 2 test, P Å .051). three groups: the single population group (SP; 34 cases, ENext, we compared the CD34 expression with Fas-medi-L), the two-population group (TP; 22 cases, M-N), and the ated apoptosis (D1000 ¢5%) using Student's t-test. As wide distributed group (WD; 8 cases, Q-T). The SP group shown in Table 5 , the expression of CD34 is higher in D1000 (E-L) was divided into three subgroups according to the ¢5% group than in D1000 õ5% group with borderline sigintensity of CD34 expression; 15 cells from 28 multiple myeloma (MM) patients, 15 were creased more than 20% in seven cases after the incubation positive. 17 The Fas was expressed in a minority (5% to 41%; with anti-Fas MoAb (1 mg/mL) for 16 hours (Table 4) . mean, 15.6%) of chronic lymphocytic leukemia (CLL) cells in 10 of 21 patients. 18 The leukemia cells from all patients DISCUSSION with ATL strongly expressed Fas. 9 Compared with these In the current study, we found that AML cells expressed studies, the intensity of Fas expression in AML was quite Fas with variable intensity (2% to 98%) in all cases. Only variable (2% to 98%), and this may reflect the heterogeneity a few studies have reported the expression of Fas on AML of AML. In normal hematopoiesis, immature cells do not cells. 15, 16 Twenty-eight percent of AML cases were positive express a significant level of Fas. 19 Fas expression becomes for Fas expression in one study, 15 whereas Fas was expressed enhanced with the maturation pathway of myeloid series.
20
on the majority of AML cells in another study, 16 which is Variable expression in AML may reflect only the difference in agreement with our results. These discrepancies may be in the maturation stage of the leukemia cell. Indeed, our explained by the different detection methods that were used, study demonstrated very immature subtype; AML-M1 immunofluorescence assay with a fluorescence microscope showed significantly weaker expression than the other suband flow cytometric analysis, respectively. types (Table 1) is that the Fas might be induced via several pathways such Fas-mediated apoptosis despite moderate expression of Fas. as cytokines and cell-cell interactions. Recent studies have However, induction of apoptosis was apparently observed shown that IFNg and TNFa can induce Fas on the surface in ATL. In multiple myeloma, some cases also were suscepof normal and tumor cells. 8, 19, 22 It could be hypothesized that tible to the treatment with anti-Fas MoAb. In a parallel study effector cells recognize AML cells and produce IFNg or of CML cells performed in our laboratory, anti-Fas MoAb TNFa enhancing Fas expression. Thereafter, different efinhibited colony growth of leukemia cells (data not shown). fector cells (CTL) would attack the target cells using the Fas
The colorimetric DNA fragmentation assay also shows that system. In the current study, we have confirmed the induc-14 leukemia samples of 24 AML cases were susceptible to tion of Fas by IFNg on AML cells (Fig 2) . Preliminary study the treatment (Table 4 ). The amount of Fas did not directly suggests that IFNg enhanced the Fas-mediated apoptosis in correlate with the induction of apoptosis, as suggested by addition to the Fas phenotype (data not shown). The possibilothers. However, Fas / (¢20%) leukemias proved to be more ity of aberrant expression of Fas in tumor cells could not be susceptible to the induction of apoptosis than Fas 0 (õ20%) excluded.
with borderline significance (P Å .051). It is possible that Several investigators have studied whether Fas mediates apoptosis may be induced by the accumulation of various apoptosis using the anti-Fas MoAb, which can act as Fas kinds of signals and the Fas pathway may be one important mechanism of apoptosis. In one study, the amount of bcl-2 agonist. 8, 9, 17, 18 Leukemia cells from CLL were resistant to From all these studies, we conclude that the induction vented antitumor agent-induced apoptosis in human myeloid leukemia U937. 28 Recently, one study concluded that selec- are still investigated. In the study using severe combined * t-test.
immunodeficiency (SCID) mice, the frequency of leukemiainitiating cells in the peripheral blood of AML patients was one in 250,000 cells and these clonogenic cells belonged pressed Fas, whereas the more mature CD34 
